News & Perspective

Aug 09, 2010

Aug 09, 2010

NIAID launches clinical trial of dengue vaccine

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has launched a clinical trial of a dengue virus vaccine, a product that eventually may help prevent a disease to which 2.5 billion people are exposed.

The launching of a trial at the Johns Hopkins Bloomberg School of Public in Baltimore and the University of Vermont in Burlington follows more than a decade of development, the NIAID said in a press release.

Feb 12, 2019

Feb 12, 2019

News Scan for Feb 12, 2019

More Saudi MERS cases
Yellow fever in Brazil
Lassa fever in Guinea and Nigeria
Zika in Mexico
Gain-of-function H5N1 studies to resume

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by



bioMérieux

  Become an underwriter»